Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.
暂无分享,去创建一个
H. Küchenhoff | G. Sturm | F. Scheipl | B. Wüthrich | W. Aberer | U. Darsow | M. Sticherling | C. Bucher | P. Campi | B. Przybilla | A. Bodzenta-Lukaszyk | F. Ruëff | T. Hawranek | M. Bilò | F. Bonifazi | R. Lang | I. Kucharewicz | U. Müller | J. Birnbaum | Cornelia Egger | M. Severino | G. Haeberli | O. Quercia | N. Reider | Michael Körner
[1] C. Camargo,et al. Compléments : Multicenter study of emergency department visits for insect sting allergies , 2011 .
[2] G. Passalacqua,et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. , 2009, The Journal of allergy and clinical immunology.
[3] J. Ring,et al. Gender difference, sex hormones, and immediate type hypersensitivity reactions , 2008, Allergy.
[4] F. Bonifazi,et al. Epidemiology of insect-venom anaphylaxis , 2008, Current opinion in allergy and clinical immunology.
[5] D. Lang. Do β-blockers really enhance the risk of anaphylaxis during immunotherapy? , 2008 .
[6] M. Greenhawt,et al. Mastocytosis and allergy , 2007, Current opinion in allergy and clinical immunology.
[7] L. Scott,et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. , 2007, Blood.
[8] Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter second update. , 2007 .
[9] K. Broadley,et al. Optimisation of the sensitisation conditions for an ovalbumin challenge model of asthma. , 2007, International immunopharmacology.
[10] B. Przybilla,et al. Mastocytosis and Hymenoptera venom allergy , 2006, Current opinion in allergy and clinical immunology.
[11] L. Schwartz. Diagnostic value of tryptase in anaphylaxis and mastocytosis. , 2006, Immunology and allergy clinics of North America.
[12] 朱丽琳,et al. Anaphylaxis , 2006 .
[13] G. Pejler,et al. Biology of mast cell tryptase , 2006 .
[14] Eman Hassan,et al. Recall Bias can be a Threat to Retrospective and Prospective Research Designs , 2005 .
[15] F. Bonifazi,et al. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice , 2005, Allergy.
[16] H. Mosbech,et al. Diagnosis of Hymenoptera venom allergy , 2005, Allergy.
[17] T. Kawakami,et al. Mast Cell Survival and Activation by IgE in the Absence of Antigen: A Consideration of the Biologic Mechanisms and Relevance1 , 2005, The Journal of Immunology.
[18] M. Dugas,et al. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus , 2005, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[19] G. Solley. Stinging and biting insect allergy: an Australian experience. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[20] G. Sturm,et al. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study , 2004, Allergy.
[21] S. Brown. Clinical features and severity grading of anaphylaxis. , 2004, The Journal of allergy and clinical immunology.
[22] Á. Avezum,et al. Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.
[23] P. Gergely,et al. Correlation between T-Cell and Mast Cell Activity in Patients with Chronic Urticaria , 2003, International Archives of Allergy and Immunology.
[24] U. Müller,et al. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[25] A. Dubois,et al. Quality of life in insect venom allergic patients , 2003, Current opinion in allergy and clinical immunology.
[26] D. Gilliland,et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. , 2003, Blood.
[27] U. Jäger,et al. Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes , 2002, Leukemia & lymphoma.
[28] P. Valent,et al. Tryptase a Novel Biochemical Marker of Acute Myeloid Leukemia , 2002, Leukemia & lymphoma.
[29] B. Przybilla,et al. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings , 2001, The Lancet.
[30] T. Yoshino,et al. Involvement of carbohydrate on phospholipase A2, a bee‐venom allergen, in in vivo antigen‐specific IgE synthesis in mice , 1999, Allergy.
[31] H. Takeda,et al. Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs. , 1997, Prostaglandins.
[32] H. Mosbech,et al. The sting challenge test in Hymenoptera venom allergy Position paper of the subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology , 1996, Allergy.
[33] B. Zweiman,et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. , 1995, The Journal of clinical investigation.
[34] G. Rasp,et al. Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis , 1994, Journal of Clinical Immunology.
[35] A. Helbling,et al. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. , 1992, The Journal of allergy and clinical immunology.
[36] R. Lockey,et al. The Hymenoptera venom study I, 1979-1982: demographics and history-sting data. , 1988, The Journal of allergy and clinical immunology.
[37] J. Ring,et al. INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES , 1977, The Lancet.
[38] R. J. Minnitt. Robert James Minnitt. , 1974, Lancet.
[39] B. Mroczko,et al. Basal serum tryptase level correlates with severity of hymenoptera sting and age. , 2007, Journal of investigational allergology & clinical immunology.
[40] D. Graft. Insect sting allergy. , 2006, The Medical clinics of North America.